FUBP1

Across TCGA pan-cancer cohorts, FUBP1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated FUBP1 data layer compared with 26 for mass-spec protein and 9 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher FUBP1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated FUBP1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and GBM show a favorable association.

HNSC, LUAD, and GBM are the cancer types where FUBP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.166	0.964	.010	41	view →
LUAD	OS	Median	All	1.000	0.767	.004	35	view →
GBM	OS	Quartile	All	0.816	0.241	.002	14	view →
CCRCC	DFS	Tertile	All	1.000	0.742	.028	5	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

FUBP1–HNSC (OS)

Open the HNSC breakdown →